Neural Therapeutics Inc. (CSE:NURL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0250
-0.0050 (-16.67%)
At close: Mar 31, 2025

Neural Therapeutics Income Statement

Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Oct '24 Jul '24 Jul '23 Jul '22
Selling, General & Admin
0.350.370.80.7
Research & Development
0.230.290.40.04
Operating Expenses
0.580.651.20.74
Operating Income
-0.58-0.65-1.2-0.74
Currency Exchange Gain (Loss)
00-00
Other Non Operating Income (Expenses)
-0.03-0.01-0-0
EBT Excluding Unusual Items
-0.61-0.67-1.21-0.74
Other Unusual Items
--0.14-1.08
Pretax Income
-0.61-0.67-1.08-1.82
Net Income
-0.61-0.67-1.08-1.82
Net Income to Common
-0.61-0.67-1.08-1.82
Shares Outstanding (Basic)
66634037
Shares Outstanding (Diluted)
66634037
Shares Change (YoY)
51.63%58.39%7.98%-
EPS (Basic)
-0.01-0.01-0.03-0.05
EPS (Diluted)
-0.01-0.01-0.03-0.05
EBIT
-0.58-0.65-1.2-0.74
Source: S&P Global Market Intelligence. Standard template. Financial Sources.